Antimetastatic and antitumor effect of platelet aggregation inhibitors.
D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009012:Mopidamol / Q000627:therapeutic use*; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009447:Neuroblastoma / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D011743:Pyrimidines / Q000627:therapeutic use*; D051381:Rats; D014183:Transplantation, Heterologous
D011743:Pyrimidines; D009012:Mopidamol